Clinical Trials on Resectable Gastric and Gastroesophageal Junction Adenocarcinoma in India
Total 9 results
-
AstraZenecaRecruitingGastric Cancer | Gastroesophageal Junction CancerCanada, Spain, United Kingdom, China, France, Italy, Vietnam, Germany, United States, India, Taiwan, Thailand, Hong Kong, Japan, Switzerland, Poland
-
Asian Institute of Gastroenterology, IndiaRecruitingGastric RefluxIndia
-
Sanjay Gandhi Postgraduate Institute of Medical...Recruiting
-
Asian Institute of Gastroenterology, IndiaCompletedGastro Esophageal Reflux DiseaseIndia
-
Jazz PharmaceuticalsBeiGene, Ltd.RecruitingGastroesophageal Adenocarcinoma | Esophageal Adenocarcinoma | Gastric NeoplasmsKorea, Republic of, Belgium, Japan, China, Netherlands, Spain, Germany, United Kingdom, Malaysia, Taiwan, Portugal, France, Italy, Australia, Turkey, Thailand, Argentina, Mexico, Ireland, Estonia, Serbia, Romania, Canada, Poland, Brazil, ... and more
-
Postgraduate Institute of Medical Education and...RecruitingHepatic Carcinoma Malignant Primary Non-ResectableIndia
-
Thrombosis Research InstituteCompletedGastric Cancer | Gastroesophageal CancerIndia
-
Hoffmann-La RocheRecruitingUnresectable Hepatocellular CarcinomaCanada, France, Korea, Republic of, China, Japan, Spain, Belgium, Croatia, Brazil, Austria, Italy, Costa Rica, Germany, Israel, Thailand, Turkey, Russian Federation, United Kingdom, Taiwan, Philippines, India, Chile, Finland, Greece, Sl... and more
-
Eli Lilly and CompanyCompletedAdenocarcinoma | Gastric CancerUnited States, Canada, Brazil, Czechia, Egypt, Korea, Republic of, Lebanon, Poland, Russian Federation, Spain, Romania, United Kingdom, Australia, Croatia, Italy, Philippines, Thailand, Argentina, Bosnia and Herzegovina, Chile, ... and more